» Articles » PMID: 37701184

Leaf Supplementation Relieves Oxidative Stress and Regulates Intestinal Flora to Ameliorate Polycystic Ovary Syndrome in Letrozole-induced Rats

Overview
Journal Food Sci Nutr
Specialty Biotechnology
Date 2023 Sep 13
PMID 37701184
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the effects of supplementation leaf (MOL) on relieving oxidative stress, anti-inflammation, changed the relative abundance of multiple intestinal flora and blood biochemical indices during letrozole-induced polycystic ovary syndrome (PCOS). Previous studies have shown that MOL has anti-inflammatory, anti-oxidation, insulin-sensitizing effects. However, whether MOL has beneficial effects on PCOS remains to be elucidated. In the current study, 10-week-old female Sprague-Dawley rats received letrozole to induce PCOS-like rats, and subsequently were treated with a MOL diet. Then, the body weight and estrus cycles were measured regularly in this period. Finally, the ovarian morphology, blood biochemical indices, anti-oxidative, intestinal flora, and anti-inflammation were observed at the end of the experiment. We found that MOL supplementation markedly decreased the body weight, significantly upregulated the expression of Sirt1, FoxO1, PGC-1α, IGF1, and substantially modulated the sex hormone level and improved insulin resistance, which may be associated with the relieves oxidative stress. Moreover, the supplementation of MOL changed the relative abundance of multiple intestinal flora, the relative abundance of , were decreased, and and were increased. These results indicate that MOL is potentially a supplementary medication for the management of PCOS.

Citing Articles

Mangiferin ameliorates polycystic ovary syndrome in rats by modulating insulin resistance, gut microbiota, and ovarian cell apoptosis.

Yong Z, Mimi C, Yingjie L, Yichen G, Yansu Y, Zhi Z Front Pharmacol. 2024; 15:1457467.

PMID: 39376609 PMC: 11456450. DOI: 10.3389/fphar.2024.1457467.


leaf supplementation relieves oxidative stress and regulates intestinal flora to ameliorate polycystic ovary syndrome in letrozole-induced rats.

Wu Y, Yang X, Hu Y, Hu X, Zhang Y, An T Food Sci Nutr. 2023; 11(9):5137-5156.

PMID: 37701184 PMC: 10494614. DOI: 10.1002/fsn3.3473.

References
1.
Moran L, Norman R, Teede H . Metabolic risk in PCOS: phenotype and adiposity impact. Trends Endocrinol Metab. 2015; 26(3):136-43. DOI: 10.1016/j.tem.2014.12.003. View

2.
Jamilian M, Mansury S, Bahmani F, Heidar Z, Amirani E, Asemi Z . The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. J Ovarian Res. 2018; 11(1):80. PMC: 6137747. DOI: 10.1186/s13048-018-0457-1. View

3.
Huang J, Zhao J, Geng X, Chu W, Li S, Chen Z . Long non-coding RNA lnc-CCNL1-3:1 promotes granulosa cell apoptosis and suppresses glucose uptake in women with polycystic ovary syndrome. Mol Ther Nucleic Acids. 2021; 23:614-628. PMC: 7819816. DOI: 10.1016/j.omtn.2020.12.008. View

4.
Vinciguerra M, Santini M, Claycomb W, Ladurner A, Rosenthal N . Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging (Albany NY). 2010; 2(1):43-62. PMC: 2837204. DOI: 10.18632/aging.100107. View

5.
Wang D, Weng Y, Zhang Y, Wang R, Wang T, Zhou J . Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ. 2020; 745:141049. DOI: 10.1016/j.scitotenv.2020.141049. View